Language selection

Search

Details for: MEZAVANT

Company: TAKEDA CANADA INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02297558MEZAVANTMESALAZINE1.2 GTABLET (DELAYED AND EXTENDED RELEASE)ORAL
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - Mesalazine-containing products - Assessing the Potential Risk of Birth Defects

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: